| Product Name | 3,5-Cyclo-Abiraterone |
| Product Code | DA-A007-12 |
| Chemical name | 3,5-Cyclo-Abiraterone |
| Synonyms | (1aR,3aR,3bS,5aS,8aS,8bR,10aR)-3a,5a-Dimethyl-6-(pyridin-3-yl)-1,1a,2,3,3a,3b,4,5,5a,8,8a,8b,9,10-tetradecahydrocyclopenta[a]cyclopropa[2,3]cyclopenta[1,2-f]naphthalen-10-ol; |
| Impurity | NA |
| CAS Number | NA |
| Alternate CAS # | NA |
| Molecular form | C24H31NO |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 349.52 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals |
| Boiling Point | NA |
| Applications | Applications 3,5-cyclo-Abiraterone is derived from Abiraterone, which is a steroidal cytochrome P 450 17-hydroxylase-17,20-lyase inhibitor, is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
| NA |
